Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | POLA1 | P09884 | 1/20 | 0.31 |
| ▸ | ST6GAL1 | P15907 | 1/20 | 0.30 |
| ▸ | TYMP | P19971 | 1/20 | 0.30 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.30 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.30 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.30 |
| ▸ | BACE1 | P56817 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL384130 | 0.87 | PDE4D (0.39) | POLA1TYMPPDE4DPDE3ASLC29A1 | |
| SCHEMBL3793142 | 0.76 | PDE4D (0.37) | TYMPPDE4DPDE3ASLC29A1BACE1 | |
| SCHEMBL3789736 | 0.72 | NT5E (0.31) | ST6GAL1TYMP | |
| SCHEMBL9083312 | 0.71 | PDE3A (0.39) | L3MBTL1POLA1ST6GAL1PDE4DPDE3A | |
| SCHEMBL23648799 | 0.70 | PDE3A (0.36) | TYMPPDE4DPDE3ASLC29A1 | |
| SCHEMBL383885 | 0.69 | PDE4D (0.44) | L3MBTL1POLA1ST6GAL1TYMPPDE4D | |
| SCHEMBL1739169 | 0.69 | PDE3A (0.32) | TYMPPDE4DPDE3ASLC29A1 | |
| SCHEMBL30514382 | 0.68 | TYMP (0.42) | ST6GAL1TYMPBACE1 | |
| SCHEMBL5201335 | 0.67 | TYMP (0.42) | ST6GAL1TYMPBACE1 | |
| SCHEMBL383849 | 0.66 | L3MBTL1 (0.40) | L3MBTL1ST6GAL1TYMP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2408306-A1 | SUBSTITUTED NUCLEOSIDE AND NUCLEOTIDE ANALOGS | Alios Biopharma, Inc. (US) | 2012-01-25 | — | — | EP | disclosed |
| WO-2010108140-A1 | SUBSTITUTED NUCLEOSIDE AND NUCLEOTIDE ANALOGS | ALIOS BIOPHARMA, INC. (US) | 2010-09-23 | — | — | WO | disclosed |